 |
Artios Pharma
Last updated: January 21, 2024
CEO Niall Martin
Country: UK | Funding: $298.6M (+)
Website: http://www.artiospharma.com
Artios is developing breakthrough cancer treatments that target DNA Damage Response (DDR) pathways to selectively kill cancer cells
Website: http://www.artiospharma.com
Artios is developing breakthrough cancer treatments that target DNA Damage Response (DDR) pathways to selectively kill cancer cells
